[Clinical study on jinmaitong composita on diabetic peripheral neuropathy].
OBJECTIVE
To verify the effect of Jinmaitong composita (JMTC) on red blood cell aldolase reductase activity (RBC-AR), RBC sorbitol (RBC-S) and nerve conductive velocity in diabetic peripheral neuropathy (DN).


METHODS
Sixty-six patients with DN were divided randomly into two groups, 33 patients in treated group treated with JMTC and 33 cases in the control group treated with Jinkui Shenqi (JKSQ), RBC-AR, RBC-S and nerve transmission speed were observed before and after three months treatment.


RESULTS
Level of RBC-AR, RBC-S apparently decreased and nerve conductive velocity increased (P < 0.05, P < 0.01) after TMTC treatment.


CONCLUSIONS
JMTC was able to improve the nerve conduction significantly with a lowering of RBC-AR and RBC-S and has good result in treating Diabetic peripheral neurophathy.
Liang
X
X
Peking Union Medical Hospital, Chinese Academy of Medical Sciences, Beijing (100730).
Cui
L
L
Guo
S
S
D000368:Aged; D000449:Aldehyde Reductase / Q000097:blood*; D003929:Diabetic Neuropathies / Q000097:blood / Q000188:drug therapy*; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D004912:Erythrocytes / Q000378:metabolism; D006801:Humans; D008297:Male; D008875:Middle Aged; D009431:Neural Conduction / Q000187:drug effects; D013012:Sorbitol / Q000097:blood
D004365:Drugs, Chinese Herbal; C583496:jinmaitong; D013012:Sorbitol; D000449:Aldehyde Reductase